Positive Sequence Biology
Shanghai
About Positive Sequence Biology
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $67.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2024)
- Website: correctsequence.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Genetics
Canonical: https://fsome.com/organization/positive-sequence-biology-99692 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.